TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background

被引:9
|
作者
Caratozzolo, Mariano Francesco [1 ]
Marzano, Flaviana [1 ]
Abbrescia, Daniela Isabel [2 ]
Mastropasqua, Francesca [1 ]
Petruzzella, Vittoria [3 ]
Calabro, Viola [4 ]
Pesole, Graziano [1 ,5 ]
Sbisa, Elisabetta [2 ]
Guerrini, Luisa [6 ]
Tullo, Apollonia [1 ]
机构
[1] CNR, CNR, Inst Biomembranes Bioenerget & Mol Biotechnol, Bari, Italy
[2] CNR, CNR, Inst Biomed Technol, Bari, Italy
[3] Univ Bari Aldo Moro, Scuola Med & Chirurgia, Dipartimento Sci Med Base Neurosci & Organi Senso, Bari, Italy
[4] Univ Naples Federico II, Dept Biol, Naples, Italy
[5] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biofarmaceut, Bari, Italy
[6] Univ Milan, Dept Biosci, Milan, Italy
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
关键词
TRIM8; p53; Delta Np63 alpha; chemoresistant tumors; caspase-1; proteasome; SQUAMOUS-CELL CARCINOMA; P63; DEGRADATION; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; SUMOYLATION; PROMOTES; ISOFORMS; TARGET;
D O I
10.3389/fonc.2019.01154
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 gene family network plays a pivotal role in the control of many biological processes and therefore the right balance between the pro-apoptotic and pro-survival isoforms is key to maintain cellular homeostasis. The stability of the p53 tumor suppressor protein and that of oncogenic Delta Np63 alpha, is crucial to control cell proliferation. The aberrant expression of p53 tumor suppressor protein and oncogenic Delta Np63 alpha contributes to tumorigenesis and significantly affects anticancer drug response. Recently, we demonstrated that TRIM8 increases p53 stability, potentiating its tumor suppressor activity. In this paper, we show that TRIM8 simultaneously reduces the level of the pro-proliferative Delta Np63 alpha protein, in both a proteasomal and caspase-1 dependent way, thereby playing a critical role in the cellular response to DNA damaging agents. Moreover, we provided evidence that Delta Np63 alpha in turn, suppresses TRIM8 gene expression by preventing p53-mediated transactivation of TRIM8, therefore suggesting the existence of a negative feedback loop. These findings indicate that TRIM8 exerts its anticancer power through a joint action that provides on one hand, the activation of the p53 tumor suppressor role, and on the other the quenching of the oncogenic Delta Np63 alpha protein activity. The enhancement of TRIM8 activity may offer therapeutic benefits and improve the management of chemoresistant tumors.
引用
收藏
页数:12
相关论文
共 26 条
  • [1] DNA damage down-regulates ΔNp63α and induces apoptosis independent of wild type p53
    Li, Xiaorong
    Chen, Jing
    Yi, Yong
    Li, Chenghua
    Zhang, Yujun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 423 (02) : 338 - 343
  • [2] Degradation of HPV20E6 by p53:: ΔNp63α and mutant p53R248W protect the wild type p53 mediated caspase-degradation
    Fei, Jian-Wei
    de Villiers, Ethel-Michele
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (01) : 108 - 116
  • [3] SENSITIVITY OF COMPETITIVE HYBRIDIZATION FOR THE DETECTION OF MUTANT P53 ALLELES IN A BACKGROUND OF WILD-TYPE
    CARPENTER, K
    MORGAN, K
    DURRANT, LG
    HARDCASTLE, JD
    KALSHEKER, N
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) : S129 - S129
  • [4] Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: Role of caspase-8 and mitochondria
    Maya Ameyar-Zazoua
    Nathanaël Larochette
    Guillaume Dorothée
    Eric Daugas
    Hedi Haddada
    Vanessa Gouloumet
    Didier Métivier
    Rodica Stancou
    Fathia Mami-Chouaib
    Guido Kroemer
    Salem Chouaib
    Cancer Gene Therapy, 2002, 9 : 219 - 227
  • [5] Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells:: Role of caspase-8 and mitochondria
    Ameyar-Zazoua, M
    Larochette, N
    Dorothée, G
    Daugas, E
    Haddada, H
    Gouloumet, V
    Métivier, D
    Stancou, R
    Mami-Chouaib, F
    Kroemer, G
    Chouaib, S
    CANCER GENE THERAPY, 2002, 9 (03) : 219 - 227
  • [6] Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma
    Gopalakrishnan, R
    Weghorst, CM
    Lehman, TA
    Calvert, RJ
    Bijur, G
    Sabourin, CLK
    Mallery, SR
    Schuller, DE
    Stoner, GD
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1997, 83 (04): : 471 - 477
  • [7] PRIMARY PROLIFERATIVE T-CELL RESPONSE TO WILD-TYPE P53 PROTEIN IN PATIENTS WITH BREAST-CANCER
    TILKIN, AF
    LUBIN, R
    SOUSSI, T
    LAZAR, V
    JANIN, N
    MATHIEU, MC
    LEFRERE, I
    CARLU, C
    ROY, M
    KAYIBANDA, M
    BELLET, D
    GUILLET, JG
    BRESSACDEPAILLERETS, B
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) : 1765 - 1769
  • [8] Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cells
    M Cascalló
    E Mercadé
    G Capellà
    F Lluís
    C Fillat
    A M Gómez-Foix
    A Mazo
    Cancer Gene Therapy, 1999, 6 : 428 - 436
  • [9] Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cells
    Cascalló, M
    Mercadé, E
    Capellà, G
    Lluís, F
    Fillat, C
    Gómez-Foix, AM
    Mazo, A
    CANCER GENE THERAPY, 1999, 6 (05) : 428 - 436
  • [10] The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-GMPS interaction promotes the growth of p53 wild-type breast cancers by degrading p53
    Su, Xi
    Feng, Chao
    Wang, Simeng
    Shi, Liang
    Gu, Qingqing
    Zhang, Haihong
    Lan, Xinhui
    Zhao, Yuelei
    Qiang, Wei
    Ji, Meiju
    Hou, Peng
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (08): : 2450 - 2464